Drug-induced prolongation of the QT interval

A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel

Sanguinetti, M. C., Jiang, C., Curran, M. E., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90340-2 · Cited by 2,422 · see citing works

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

Curran, M. E., Splawski, I., Timothy, K. W., Vincent, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,253 · see citing works

Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias

Wang, Q., Curran, M. E., Splawski, I., Burn, T. C., Millholland, J. M., Raay, T. J. V., Shen, J., Timothy, K. W., Vincent, G. M., Jager, T. D., et al. (1996) · Nature Genetics · doi:10.1038/ng0196-17 · Cited by 1,756 · see citing works

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

Wang, Q. K., Shen, J., Splawski, I., Atkinson, D. L., Li, Z., Robinson, J. L., Moss, A. J., Towbin, J. A., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90359-3 · Cited by 1,682 · see citing works

Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden death

Jervell, A., & Lange-Nielsen, F. (1957) · American Heart Journal · doi:10.1016/0002-8703(57)90079-0 · Cited by 1,603 · see citing works

Drug-induced hepatotoxicity

Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594 · see citing works

Risk Stratification in the Long-QT Syndrome

Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,456 · see citing works

Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction

Torp-Pedersen, C. T., Møller, M., Bloch-Thomsen, P.-E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J. E., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012 · see citing works

Timing of new black box warnings and withdrawals for prescription medications

Lasser, K. E. (2002) · JAMA · doi:10.1001/jama.287.17.2215 · Cited by 1,005 · see citing works

Molecular and Cellular Mechanisms of Cardiac Arrhythmias

Keating, M. T., & Sanguinetti, M. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00243-4 · Cited by 1,003 · see citing works

Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs

Makkar, R. (1993) · JAMA · doi:10.1001/jama.270.21.2590 · Cited by 972 · see citing works

Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death

Mohler, P. J., Schott, J.-J., Gramolini, A. O., Dilly, K. W., Guatimosim, S., duBell, W. H., Song, L.-S., Haurogné, K., Kyndt, F., Ali, M. E., et al. (2003) · Nature · doi:10.1038/nature01335 · Cited by 957 · see citing works

A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN.

Ward, O. C. (1964) · PubMed · Cited by 830 · see citing works

Low Penetrance in the Long-QT Syndrome

Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999) · Circulation · doi:10.1161/01.cir.99.4.529 · Cited by 814 · see citing works

Mutations in the hminK gene cause long QT syndrome and suppress lKs function

Splawski, I., Tristani‐Firouzi, M., Lehmann, M. H., Sanguinetti, M. C., & Keating, M. T. (1997) · Nature Genetics · doi:10.1038/ng1197-338 · Cited by 767 · see citing works

Terfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences

Honig, P. K. (1993) · JAMA · doi:10.1001/jama.1993.03500120051025 · Cited by 664 · see citing works

Taking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes

Roden, D. M. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00148.x · Cited by 662 · see citing works

Mechanism of the Cardiotoxic Actions of Terfenadine

Woosley, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500120070028 · Cited by 646 · see citing works

Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.

Velebit, V., Podrid, P. J., Lown, B., Cohen, B. H., & Graboys, T. B. (1982) · Circulation · doi:10.1161/01.cir.65.5.886 · Cited by 629 · see citing works

Quinidine Syncope

Selzer, A., & WRAY, H. W. (1964) · Circulation · doi:10.1161/01.cir.30.1.17 · Cited by 564 · see citing works

Torsades de pointes occurring in association with terfenadine use

Monahan, B. P. (1990) · JAMA · doi:10.1001/jama.264.21.2788 · Cited by 554 · see citing works

Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes

Yang, P., Kanki, H., Drolet, B., Yang, T., Wei, J., Viswanathan, P. C., Hohnloser, S. H., Shimizu, W., Schwartz, P. J., Stanton, M. S., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014448.19052.4c · Cited by 551 · see citing works

Variant of SCN5A Sodium Channel Implicated in Risk of Cardiac Arrhythmia

Splawski, I., Timothy, K. W., Tateyama, M., Clancy, C. E., Malhotra, A., Beggs, A. H., Cappuccio, F. P., Sagnella, G. A., Kass, R. S., & Keating, M. T. (2002) · Science · doi:10.1126/science.1073569 · Cited by 523 · see citing works

Age- and Sex-Related Differences in Clinical Manifestations in Patients With Congenital Long-QT Syndrome

Locati, E. H., Zaręba, W., Moss, A. J., Schwartz, P. J., Vincent, G. M., Lehmann, M. H., Towbin, J. A., Priori, S. G., Napolitano, C., Robinson, J. L., et al. (1998) · Circulation · doi:10.1161/01.cir.97.22.2237 · Cited by 490 · see citing works

Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care

Roden, D. M., Woosley, R. L., & Primm, R. K. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90010-4 · Cited by 489 · see citing works

Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation

Stambler, B. S., Wood, M. A., Ellenbogen, K. A., Perry, K. T., Wakefield, L. K., & VanderLugt, J. T. (1996) · Circulation · doi:10.1161/01.cir.94.7.1613 · Cited by 485 · see citing works

A common polymorphism associated with antibiotic-induced cardiac arrhythmia

Sesti, F., Abbott, G. W., Wei, J., Murray, K. T., Saksena, S. V., Schwartz, P. J., Priori, S. G., Roden, D. M., George, A. L., & Goldstein, S. A. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180223197 · Cited by 479 · see citing works

Torsade de pointes: The long-short initiating sequence and other clinical features: observations in 32 patients

Kay, G. N., Plumb, V. J., Arciniegas Joaquin, G., Henthorn, R. W., & L, W. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80226-5 · Cited by 463 · see citing works

Characteristics and Distribution of M Cells in Arterially Perfused Canine Left Ventricular Wedge Preparations

Yan, G., Shimizu, W., & Antzelevitch, C. (1998) · Circulation · doi:10.1161/01.cir.98.18.1921 · Cited by 451 · see citing works

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

Malík, M., Färbom, P., Batchvarov, V., Hnatkova, K., & Camm, A. J. (2002) · Heart · doi:10.1136/heart.87.3.220 · Cited by 437 · see citing works

Extracellular Potassium Modulation of Drug Block of IKr

Yang, T., & Roden, D. M. (1996) · Circulation · doi:10.1161/01.cir.93.3.407 · Cited by 428 · see citing works

The Electrophysiological Mechanism of Ventricular Arrhythmias in the Long QT Syndrome

El‐Sherif, N., Caref, E. B., Yin, H. S., & Restivo, M. (1996) · Circulation Research · doi:10.1161/01.res.79.3.474 · Cited by 425 · see citing works

[Ventricular tachycardia with 2 variable opposing foci].

Dessertenne, F. (1966) · PubMed · Cited by 414 · see citing works

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

Haverkamp, W. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2249 · Cited by 414 · see citing works

Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome

Shimizu, W., & Antzelevitch, C. N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00582-3 · Cited by 379 · see citing works

Sex Hormones Prolong the QT Interval and Downregulate Potassium Channel Expression in the Rabbit Heart

Drici, M., Burklow, T. R., Haridasse, V., Glazer, R. I., & Woosley, R. L. (1996) · Circulation · doi:10.1161/01.cir.94.6.1471 · Cited by 371 · see citing works

Mechanism of Block and Identification of the Verapamil Binding Domain to HERG Potassium Channels

Zhang, S., Zhou, Z., Gong, Q., Makielski, J. C., & January, C. T. (1999) · Circulation Research · doi:10.1161/01.res.84.9.989 · Cited by 366 · see citing works

KVLQT1 C-Terminal Missense Mutation Causes a Forme Fruste Long-QT Syndrome

Donger, C., Denjoy, I., Berthet, M., et al. (1997) · Circulation · doi:10.1161/01.cir.96.9.2778 · Cited by 349 · see citing works

Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length.

Roden, D. M., & Hoffman, B. F. (1985) · Circulation Research · doi:10.1161/01.res.56.6.857 · Cited by 343 · see citing works

Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia.

Brachmann, J., Scherlag, B. J., Rosenshtraukh, L. V., & Lazzara, R. (1983) · Circulation · doi:10.1161/01.cir.68.4.846 · Cited by 312 · see citing works

Unique Topographical Distribution of M Cells Underlies Reentrant Mechanism of Torsade de Pointes in the Long-QT Syndrome

Akar, F. G., Yan, G., Antzelevitch, C. N., & ROSENBAUM, D. S. (2002) · Circulation · doi:10.1161/hc1002.105231 · Cited by 301 · see citing works

Evidence for a Cardiac Ion Channel Mutation Underlying Drug‐Induced QT Prolongation and Life‐Threatening Arrhythmias

Napolitano, C., Schwartz, P. J., Brown, A. M., Ronchetti, E., Bianchi, L. K., Pinnavaia, A., Aquaro, G. D., & Priori, S. G. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb00033.x · Cited by 300 · see citing works

Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: Cohort study using administrative data

Hennessy, S., Bilker, W. B., Knauss, J. S., Margolis, D. J., Kimmel, S. E., Reynolds, R. F., Glasser, D. B., Morrison, M. F., & Strom, B. L. (2002) · BMJ · doi:10.1136/bmj.325.7372.1070 · Cited by 261 · see citing works

Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations

Carlsson, L. M. S., Abrahamsson, C., Andersson, B., Duker, G., & Schiller-Linhardt, G. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2186 · Cited by 213 · see citing works

Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic Leukemia

Ohnishi, K., Yoshida, H., Shigeno, K., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-11-200012050-00012 · Cited by 212 · see citing works

Drug Block of I Kr : Model Systems and Relevance to Human Arrhythmias

Yang, T., Snyders, D. J., & Roden, D. M. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200111000-00010 · Cited by 172 · see citing works

Safety of Newly Approved Drugs

Temple, R. J., & Himmel, M. H. (2002) · JAMA · doi:10.1001/jama.287.17.2273 · Cited by 172 · see citing works

Cardiotoxic effect with convulsions in terfenadine overdose.

Davies, A., Harindra, V., McEwan, A., & Ghose, R. R. (1989) · BMJ · doi:10.1136/bmj.298.6669.325 · Cited by 164 · see citing works

The Canine Purkinje Fiber: An In Vitro Model System for Acquired Long QT Syndrome and Drug-Induced Arrhythmogenesis

Gintant, G. A., Limberis, J. T., McDermott, J. S., Wegner, C. D., & Cox, B. F. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200105000-00012 · Cited by 157 · see citing works

Impact of Sex and Gonadal Steroids on Prolongation of Ventricular Repolarization and Arrhythmias Induced byIK-Blocking Drugs

Pham, T. V., Sosunov, E. A., Gainullin, R. Z., Danilo, P., & Rosen, M. R. (2001) · Circulation · doi:10.1161/01.cir.103.17.2207 · Cited by 143 · see citing works

Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variability

Pratt, C. M., Ruberg, S. J., Morganroth, J., McNutt, B. E., Woodward, J. K., Harris, S. I., Ruskin, J. N., & Moyé, L. A. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90525-6 · Cited by 141 · see citing works

Cardiac repolarization: Current knowledge, critical gaps, and new approaches to drug development and patient management

Anderson, M. E., Al‐Khatib, S. M., Roden, D. M., & Califf, R. M. (2002) · American Heart Journal · doi:10.1067/mhj.2002.125804 · Cited by 136 · see citing works

Pharmacological response of quinidine induced early afterdepolarisations in canine cardiac Purkinje fibres: insights into underlying ionic mechanisms

Nattel, S., & Quantz, M. (1988) · Cardiovascular Research · doi:10.1093/cvr/22.11.808 · Cited by 128 · see citing works

Cardiac repolarization: Current knowledge, critical gaps, and new approaches to drug development and patient management

Anderson, M. E., Al‐Khatib, S. M., Roden, D. M., & Califf, R. M. (2002) · American Heart Journal · doi:10.1016/s0002-8703(02)80007-2 · Cited by 124 · see citing works

Electrocardiographic and Clinical Predictors of Torsades de Pointes Induced by Almokalant Infusion in Patients with Chronic Atrial Fibrillation or Flutter: A Prospective Study

Houltz, B., Darpö, B., Edvardsson, N. G., Blomström, P., Brachmann, J., Crijns, H. J. G. M., Jensen, S. M., Svernhage, E., Vallin, H., & Swedberg, K. B. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00150.x · Cited by 117 · see citing works

Drug‐Induced Afterdepolarizations and Triggered Activity Occur in a Discrete Subpopulation of Ventricular Muscle Cells (M Cells) in the Canine Heart:

Sicouri, S., & Antzelevitch, C. (1993) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1993.tb01211.x · Cited by 108 · see citing works

Pharmacies and Prevention of Potentially Fatal Drug Interactions

Cavuto, N. J. (1996) · JAMA · doi:10.1001/jama.1996.03530380028022 · Cited by 107 · see citing works

Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences

Honig, P. K. (1993) · JAMA · doi:10.1001/jama.269.12.1513 · Cited by 102 · see citing works

Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent?

Viskin, S., Fish, R., Zeltser, D., Belhassen, B., Heller, K., Brosh, D., Laniado, S., & Barron, H. V. (2000) · Heart · doi:10.1136/heart.83.6.661 · Cited by 99 · see citing works

A new approach for TU complex characterization

Vila, X. A., Gang, Y., Presedo, J., et al. (2000) · IEEE Transactions on Biomedical Engineering · doi:10.1109/10.844227 · Cited by 98 · see citing works

Mechanism of the cardiotoxic actions of terfenadine

Woosley, R. L. (1993) · JAMA · doi:10.1001/jama.269.12.1532 · Cited by 94 · see citing works

Amiodarone and Torsade de Pointes

Lazzara, R. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-7-549 · Cited by 90 · see citing works

Exaggerated QT prolongation after cardioversion of atrial fibrillation

Choy, A. M. J., Darbar, D., Dell’Orto, S., & Roden, D. M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00226-0 · Cited by 89 · see citing works

Effects of cisapride on QT interval in children

Khongphatthanayothin, A., Lane, J., Thomas, D., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70177-5 · Cited by 85 · see citing works

Calmodulin Inhibitor W-7 Unmasks a Novel Electrocardiographic Parameter That Predicts Initiation of Torsade de Pointes

Gbadebo, T. D., Trimble, R. W., Khoo, M. S. C., Temple, J., Roden, D. M., & Anderson, M. E. (2002) · Circulation · doi:10.1161/hc0602.103724 · Cited by 81 · see citing works

Mechanism of arrhythmogenicity of the short–long cardiac sequence that precedes ventricular tachyarrhythmias in the long QT syndrome

El‐Sherif, N., Caref, E. B., Chinushi, M., & Restivo, M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00700-1 · Cited by 74 · see citing works

Testosterone Diminishes the Proarrhythmic Effects of Dofetilide in Normal Female Rabbits

Pham, T. V., Sosunov, E. A., Anyukhovsky, E. P., Danilo, P., & Rosen, M. R. (2002) · Circulation · doi:10.1161/01.cir.0000033596.21845.d8 · Cited by 69 · see citing works

Block of IKs Does Not Induce Early Afterdepolarization Activity but Promotes β‐Adrenergic Agonist‐Induced Delayed Afterdepolarization Activity

BURASHNTKOV, A., & Antzelevitch, C. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb00342.x · Cited by 62 · see citing works

Molecular Basis of Cardiovascular Drug Metabolism

Abernethy, D. R., & Flockhart, D. A. (2000) · Circulation · doi:10.1161/01.cir.101.14.1749 · Cited by 54 · see citing works

Transient proarrhythmic state following atrioventricular junction radiofrequency ablation: pathophysiologic mechanisms and recommendations for management

Nowinski, K., Gadler, F., Jensen‐Urstad, M., & Bergfeldt, L. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01274-3 · Cited by 53 · see citing works

Reduced repolarization reserve in ventricular myocytes from female mice

Wu, Y. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00387-x · Cited by 53 · see citing works

Drug Labeling Revisions—Guaranteed to Fail?

Woosley, R. L. (2000) · JAMA · doi:10.1001/jama.284.23.3047 · Cited by 45 · see citing works

Arsenic Trioxide Therapy for Relapsed Acute Promyelocytic Leukemia: an Useful Salvage Therapy

Huang, S., Yang, C.-H., & Chen, Y. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009087019 · Cited by 36 · see citing works

Temporal decline in filling prescriptions for terfenadine closely in time with those for either ketoconazole or erythromycin*

Burkhart, G. A., Sevka, M. J., Temple, R., & Honig, P. K. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90185-5 · Cited by 35 · see citing works

Torsades de Pointes Associated with Terfenadine in a Case of Liver Cirrhosis and Hepatocellular Carcinoma.

Kamisako, T., Adachi, Y., Nakagawa, H., et al. (1995) · Internal Medicine · doi:10.2169/internalmedicine.34.92 · Cited by 30 · see citing works

Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem

Singh, B. N. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90824-5 · Cited by 30 · see citing works

Amiodarone and torsades de pointes

Jorens, P. G., van den Heuvel, P. A., & Parizel, G. A. (1990) · American Heart Journal · doi:10.1016/0002-8703(90)90276-4 · Cited by 16 · see citing works

Pharmacies and prevention of potentially fatal drug interactions

Cavuto, N. J. (1996) · JAMA · doi:10.1001/jama.275.14.1086 · Cited by 12 · see citing works

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893 · see citing works

Atypical antipsychotic drugs and the risk of sudden cardiac death

Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194 · see citing works

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.10.023 · Cited by 1,031 · see citing works

Prevention of Torsade de Pointes in Hospital Settings: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

Drew, B. J., Ackerman, M. J., Funk, M., Gibler, W. B., Kligfield, P., Menon, V., Philippides, G. J., Roden, D. M., & Zareba, W. (2010) · Circulation · doi:10.1161/circulationaha.109.192704 · Cited by 821 · see citing works

Practice Standards for Electrocardiographic Monitoring in Hospital Settings: An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: Endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses

Drew, B. J., Califf, R. M., Funk, M., Kaufman, E. S., Krucoff, M. W., Laks, M. M., Macfarlane, P. W., Sommargren, C., Swiryn, S., & Van Hare, G. F. (2004) · Circulation · doi:10.1161/01.cir.0000145144.56673.59 · Cited by 609 · see citing works

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000548 · Cited by 412 · see citing works

Targeted Cancer Therapy: Giving Histone Deacetylase Inhibitors All They Need To Succeed

Gryder, B. E., Sodji, Q. H., & Oyelere, A. K. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.3 · Cited by 404 · see citing works

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation

Matsa, E., Rajamohan, D., Dick, E., Young, L., Mellor, I., Staniforth, A., & Denning, C. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr073 · Cited by 389 · see citing works

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy

Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477313 · Cited by 270 · see citing works

Antipsychotic Drugs and the Risk of Ventricular Arrhythmia and/or Sudden Cardiac Death: A Nation-wide Case-Crossover Study

Wu, C., Tsai, Y., & Tsai, H. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001568 · Cited by 191 · see citing works

Management of patients with palpitations: a position paper from the European Heart Rhythm Association

Raviele, A., Giada, F., Bergfeldt, L., Blanc, J. J., Blomstrom-Lundqvist, C., Mont, L., Morgan, J. M., Raatikainen, M. J. P., Steinbeck, G., Viskin, S., et al. (2011) · Europace · doi:10.1093/europace/eur130 · Cited by 149 · see citing works

Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study

Hinterseer, M., Thomsen, M. B., Beckmann, B.-M., Pfeufer, A., Schimpf, R., Wichmann, H.-E., Steinbeck, G., Vos, M. A., & Kaab, S. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm586 · Cited by 126 · see citing works

A Systematic Review of Depression and Anxiety in Patients with Atrial Fibrillation: The Mind-Heart Link

Patel, D., Mc Conkey, N. D., Sohaney, R., Mc Neil, A., Jedrzejczyk, A., & Armaganijan, L. (2013) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2013/159850 · Cited by 124 · see citing works

QT Interval Screening in Methadone Maintenance Treatment: Report of a SAMHSA Expert Panel

Martin, J. A., Campbell, A., Killip, T., Kotz, M., Krantz, M. J., Kreek, M. J., McCarroll, B. A., Mehta, D., Payte, J. T., Stimmel, B., et al. (2011) · Journal of Addictive Diseases · doi:10.1080/10550887.2011.610710 · Cited by 87 · see citing works

Does this patient with palpitations have a cardiac arrhythmia?

Thavendiranathan, P. (2009) · JAMA · doi:10.1001/jama.2009.1673 · Cited by 75 · see citing works

Ventricular repolarization measures for arrhythmic risk stratification

Monitillo, F. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i1.57 · Cited by 66 · see citing works

Cardiovascular Disease in Women

Stock, E. O., & Redberg, R. (2012) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2012.07.001 · Cited by 65 · see citing works

A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome

Castelletti, S., Dagradi, F., Goulene, K., Danza, A. I., Baldi, E., Stramba-Badiale, M., & Schwartz, P. J. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.097 · Cited by 63 · see citing works

Pharmacoepidemiology of QT‐interval prolonging drug administration in critically ill patients

Freeman, B. D., Dixon, D. J., Coopersmith, C. M., Zehnbauer, B. A., & Buchman, T. G. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1637 · Cited by 48 · see citing works

Functional Properties of Engineered Heart Slices Incorporating Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Blazeski, A., Lowenthal, J., Zhu, R., Ewoldt, J., Boheler, K. R., & Tung, L. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.04.002 · Cited by 40 · see citing works

Prolonged QT interval corrected for heart rate during diabetic ketoacidosis in children

Kuppermann, N., Park, J., Glatter, K., Marcin, J. P., & Glaser, N. S. (2008) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.162.6.544 · Cited by 41 · see citing works

Drug-induced long-QT syndrome and torsade de pointes: an underrated problem?

Rao, P., & Kowey, P. R. (2014) · Europace · doi:10.1093/europace/eut331 · Cited by 4 · see citing works

Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review

Dumitru, C. N., Marcu, T., Dumitru, A. O., Tudor, S. S., Ferțu, I. D., Elisei, A.-M., & Goroftei, L. (2026) · Pharmaceuticals · doi:10.3390/ph19081313 · Cited by 2 · see citing works

Hypocalcemia Presenting as Life Threatening Torsades de Pointes with Prolongation of QTc Interval

Chhabra, S. T., Mehta, S. M., Chhabra, S., Singla, M., Aslam, N., Mohan, B., & Wander, G. S. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0684-z · Cited by 9 · see citing works

Cesium-Induced Acquired QT Prolongation Causing Ventricular Tachycardia and Torsades De Pointes: Fatal Complication of Over-the-Counter Supplements

Hetavi, M., Calderon, D., Patel, A. S., et al. (2019) · Journal of Medical Cases · doi:10.14740/jmc3309 · Cited by 1 · see citing works

QTc Prolongation and Torsades de Pointes

Srivastava, A., & Littlejohn, J. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780190082482.003.0013 · Cited by 2 · see citing works

Predicting the degree of drug-induced QT prolongation and the risk for torsades de pointes

Ding, C. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.04.007 · Cited by 2 · see citing works

QT interval prolongation, torsades de pointes and psychotropic medication

Kyziridis, T. C. (2022) · Hellenic Journal of Nursing Science · doi:10.24283/hjns.202215